Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Absenteeism: The Bottom-line Killer
- Absenteeism has a material effect on the bottom line of most companies, yet few managers really understand the magnitude of the problem and the considerable direct and indirect costs. The first step in reducing costs is to use an automated absence management solution to identify the absence rate and the...
- White papers 2005-08-10
Additional Resources
- CIRCADIAN TECHNOLOGIES: Proposed listing of Axon Instruments on the Australian Stock Exchange.
- M2 PRESSWIRE-13 July 1999-CIRCADIAN TECHNOLOGIES: Proposed listing of Axon Instruments on the Australian Stock Exchange C1994-99 M2 COMMUNICATIONS LTD RDATE:120799 * Aud$10m capital raising The Board of Directors are pleased to advise that one of Circadian's (Circadian Technologies...
- Research articles 1999-07-13
- CIRCADIAN TECHNOLOGIES: Re. proposed ASX listing of Ax Axon Instruments Inc. ('Axon').
- M2 PRESSWIRE-20 August 1999-CIRCADIAN TECHNOLOGIES: Re. proposed ASX listing of Axon Instruments Inc. ('Axon') C1994-99 M2 COMMUNICATIONS LTD RDATE:200899 Further to our recent Australian Stock Exchange announcements dated 13th July 1999 and 4th August 1999 relating to the proposed listing of...
- Research articles 1999-08-20
- Circadian shares up on Amrad appointments.
- Jul 02, 2003 (The Age - ABIX via COMTEX) An executive director of Circadian Technologies has been appointed to the board of the Amrad Corporation. The appointment of Graeme Kaufman is seen as a sign of Circadian's growing influence over Amrad, and on 2...
- Research articles 2003-07-02
- Buyback plan brightens Circadian stock price.
- Apr 08, 2003 (The Age - ABIX via COMTEX) Australian biotechnology investment group, Circadian Technologies, announced a share buyback on 8 April 2003. Following news of Circadian's buyback plan, the group's stock gained 32 to end the day $A0.35 higher at $A1.45. At this...
- Research articles 2003-04-08
- Circadian losses rise in tech investments.
- Jan 30, 2002 The Age ABIX via COMTEX -- Circadian Technologies has reported that net losses for the six months to December 2001 grew by eight per cent. The figure increased from $A593,000 to $A640,000, mainly as the result of charges relating to the...
- Research articles 2002-01-29
- Perfect antisense.
- January, 2002 Shares ABIX via COMTEX -- Antisense Therapeutics is a spin-off of the Australian biotechnological company, Circadian Technologies. In December 2001, Circadian hopes to raise $A13 million in a float of Antisense on the Australian Stock Exchange. Antisense is using a revolutionary ...
- Research articles 2001-12-31
- Circadian leads cancer therapy float.
- Byline: Rebecca Urban May 01, 2006 (The Age - ABIX via COMTEX) -- Circardian Technologies' MD, Leon Serry, has high hopes for anti-cancer treatments in the new field of anti-angiogenesis. The Melbourne-based biotechnology incubator has joined with the Ludwig Institute for Cancer ...
- Research articles 2006-05-01
- Fat off the land.
- Apr 11, 2002 BRW ABIX via COMTEX -- Metabolic Pharmaceuticals listed on the Australian sharemarket in 1998. The Australian biotechnology firm has raised $A18m between that time and 2002. A further capital raising is planned for 2002 or beyond. Circadian Technologies spun off the...
- Research articles 2002-04-11
- Lexington, Mass., Researcher Details the Growth, Perils of Nighttime Work.
- By Kimberly Blanton, The Boston Globe Knight Ridder/Tribune Business News Nov. 30--More retailers are staying open late, even more so during holidays. That is just one explanation for the explosive growth in jobs requiring employees to work evenings or...
- Research articles 2003-11-30
- Amrad 25pc share price dive courts board coup.
- Mar 24, 2002 The Australian Financial Review ABIX via COMTEX -- Frustration with the management of the Australian-listed medical research company, Amrad, is said to be growing. Sources say that the company's major shareholder, Circadian Technologies, is threatening a boardroom coup. On 22 March...
- Research articles 2002-03-24
- Trading Halt.
- Feb 4, 2002 Australian Stock Exchange Announcements ABIX via COMTEX -- Biotechnology investment company, Circadian Technologies, requested on 4 February 2002 that a halt be placed on trading in its shares. The halt was requested pending an announcement from Metabolic Pharmaceuticals, which has...
- Research articles 2002-02-03
- << Previous
- page 1 of 1
- Next >>
